FDA Announces Approval of Guidance on Formal Meetings for Prescription Drug User Fee Act Product

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a collection of information related to formal meetings with sponsors and applicants for prescription drug products under the Prescription Drug User Fee Act (PDUFA).